An Endometrial Cancer Chemoprevention Study of Metformin versus No Treatment in Women with a Body Mass Index (BMI) >/= 35 kg.m2 and hyperinsulinemia
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Metformin (Primary)
- Indications Endometrial cancer
- Focus Biomarker; Pharmacodynamics
- 05 Jun 2019 Biomarkers information updated
- 04 May 2013 New source identified and integrated (M.D. Anderson Cancer Center; 2011-0739).
- 03 May 2013 Planned end date changed from 1 Jul 2019 to 1 May 2019 as reported by ClinicalTrials.gov.